Tenecteplase: a promising new fibrinolytic agent
| Autor: | De Jong Mj, Sabadie-Garretson W |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
medicine.medical_specialty Acute coronary syndrome Unstable angina business.industry Tenecteplase Emergency Nursing Middle Aged Critical Care Nursing medicine.disease Fibrinolytic Agents Internal medicine Tissue Plasminogen Activator Cardiology medicine Humans Myocardial infarction Acute Coronary Syndrome Drug Monitoring business Acute mi Fibrinolytic agent medicine.drug |
| Zdroj: | Dimensions of critical care nursing : DCCN. 20(6) |
| ISSN: | 1538-8646 |
| Popis: | Acute coronary syndrome can mean anything from unstable angina to acute myocardial infarction (MI) with ST-segment elevation. Tenecteplase, a new fibrinolytic agent used to treat ST-segment elevation acute MI, has some advantages over other fibrinolytic agents. This article describes tenecteplase's actions, indications, contraindications, and use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|